Institutional shares held 45.4 Million
35.2K calls
40.6K puts
Total value of holdings $92.6M
$71K calls
$82K puts
Market Cap $115M
56,527,200 Shares Out.
Institutional ownership 80.34%
# of Institutions 127


Latest Institutional Activity in VTYX

Top Purchases

Q2 2025
Pallas Capital Advisors LLC Shares Held: 17.8K ($36.4K)
Q2 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 29.7K ($60.5K)
Q2 2025
Uma Financial Services, Inc. Shares Held: 833 ($1.7K)
Q2 2025
Palumbo Wealth Management LLC Shares Held: 27.3K ($55.6K)
Q2 2025
Rise Advisors, LLC Shares Held: 870 ($1.77K)

Top Sells

Q2 2025
Fortitude Family Office, LLC Shares Held: 830 ($1.69K)
Q1 2025
Ubs Group Ag Shares Held: 310K ($632K)
Q1 2025
Bank Of America Corp Shares Held: 1.02M ($2.07M)
Q1 2025
Citadel Advisors LLC Shares Held: 1.39M ($2.84M)
Q1 2025
Morgan Stanley Shares Held: 876K ($1.79M)

About VTYX

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002, an oral sphingosine 1 phosphate receptor 1 modulator that is in phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 (NLRP3) inflammasome inhibitor for the treatment of systemic inflammatory diseases, such as cardiovascular, hepatic, renal, and rheumatologic diseases which is in phase I clinical trials. In addition, the company develops CNS-penetrant NLRP3 inhibitors for the treatment of Alzheimer disease, Parkinson disease, amyotrophic lateral sclerosis, and multiple sclerosis. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.


Insider Transactions at VTYX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
1M Shares
From 6 Insiders
Open market or private purchase 630K shares
Exercise of conversion of derivative security 367K shares
Grant, award, or other acquisition 4.75K shares
Sell / Disposition
3.11M Shares
From 2 Insiders
Other acquisition or disposition 3.07M shares
Open market or private sale 36.2K shares

Track Institutional and Insider Activities on VTYX

Follow Ventyx Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VTYX shares.

Notify only if

Insider Trading

Get notified when an Ventyx Biosciences, Inc. insider buys or sells VTYX shares.

Notify only if

News

Receive news related to Ventyx Biosciences, Inc.

Track Activities on VTYX